Phytochemicals as potential IKK-β inhibitor for the treatment of cardiovascular diseases in plant preservation: terpenoids, alkaloids, and quinones

Inflammopharmacology. 2020 Feb;28(1):83-93. doi: 10.1007/s10787-019-00640-2. Epub 2019 Sep 5.

Abstract

Modulation of inhibitor kappa B kinase-beta (IKK-β) kinase activity could be useful for preventing inflammation that serves an efficient role in protection against cardiovascular diseases (CVDs). IKK-β induces inflammation by activating transcription factor NF-kappa B (NF-κB) through phosphorylation of IκB. Therefore, IKK-β is considered an interesting target for protecting and treating CVDs. The cardioprotective potential of terpenoids, alkaloids and quinines may be related to modulating inflammatory responses. In this study, the interactions between different classes of inhibitors and IKK-β were investigated, through the application of SystemsDock. Molecular docking results showed that Diosgenin and Ginsenoside Re were the top docking score compounds. Diosgenin and Ginsenoside Re are the most promising IKK-β inhibitors in terpenoids, alkaloids, and quinones. Diosgenin and Ginsenoside Re could be helpful to find the lead compounds on designing and developing novel cardioprotective agents.

Keywords: Alkaloids; Cardiovascular diseases; Ikk-β inhibitor; Molecular docking; Quinones; Terpenoids.

Publication types

  • Review

MeSH terms

  • Alkaloids / pharmacology*
  • Animals
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / metabolism
  • Humans
  • I-kappa B Proteins / antagonists & inhibitors*
  • Phytochemicals / pharmacology*
  • Quinones / pharmacology*
  • Terpenes / pharmacology*

Substances

  • Alkaloids
  • I-kappa B Proteins
  • Phytochemicals
  • Quinones
  • Terpenes